International Journal of Cancer

Journal Abbreviation: INT J CANCER
ISSN: 0020-7136
Publisher: Wiley-Blackwell

Publications (67)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance (2020) Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, et al. Journal article Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma (2020) Brill R, Uller W, Huf V, Müller-Wille R, Schmid I, Pohl A, Häberle B, et al. Journal article First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial (2020) Staehler M, Panic A, Goebell P, Merling M, Potthoff K, Herrmann E, de Geeter P, et al. Journal article Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann M, et al. Journal article β6-integrin serves as a novel serum tumor marker for colorectal carcinoma (2019) Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, et al. Journal article, Original article Modeling and multiscale characterization of the quantitative imaging based fibrosis index reveals pathophysiological, transcriptome and proteomic correlates of lung fibrosis induced by fractionated irradiation (2019) Zhou C, Moustafa MR, Cao L, Kriegsmann M, Winter M, Schwager C, Jones B, et al. Journal article Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation (2019) Kruber P, Angay O, Winkler A, Boesl MR, Kneitz S, Heinze KG, Gessler M Journal article Senescence markers: Predictive for response to checkpoint inhibitors (2019) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Journal article Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry (2019) Staehler M, Goebell P, Müller L, Emde TO, Wetzel N, Kruggel L, Jänicke M, Marschner N Journal article
1 2 3 4 5 ... 7